Phospholipase C-β1 and schizophrenia-related behaviors

Hae-Young Koh1

  • 1Center for Neuroscience, Brain Science Institute, Korea Institute of Science and Technology, Hwarangno 14-gil 5, Seongbuk-gu, Seoul 136-791, South Korea.

Insights

Phospholipase C-β1 (PLC-β1) signaling is implicated in schizophrenia pathogenesis. Studies on PLC-β1 knockout mice reveal its role in schizophrenia-related behaviors, suggesting therapeutic targets.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Psychiatry

Background:

  • Abnormal phospholipase C-β1 (PLC-β1) expression in schizophrenia patients suggests its involvement.
  • Genetic linkage studies highlight the PLC-β1 signaling system's role in schizophrenia.
  • PLC-β1 knockout mice exhibit behavioral phenotypes relevant to schizophrenia.

Purpose of the Study:

  • To review current knowledge on schizophrenia-related behaviors.
  • To discuss the potential involvement of PLC-β1 signaling in the neural mechanisms of these behaviors.
  • To suggest future research directions for PLC-β1 in schizophrenia.

Main Methods:

  • Literature review of studies on PLC-β1 and schizophrenia.
  • Analysis of behavioral phenotypes in PLC-β1 knockout mice.
  • Examination of PLC-β1's known interactions with neurotransmitter systems.

Main Results:

  • PLC-β1 is linked to muscarinic acetylcholine, glutamatergic, serotonergic, and oxytocinergic systems.
  • Schizophrenia-related behaviors are observed in PLC-β1 deficient models.
  • These findings support the hypothesis of PLC-β1 signaling pathway involvement in schizophrenia.

Conclusions:

  • PLC-β1 signaling pathways are likely involved in the neural systems disrupted in schizophrenia.
  • Understanding PLC-β1's role may offer new therapeutic strategies for schizophrenia.
  • Further research is warranted to elucidate specific mechanisms.

Related Concept Videos

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
Positive Symptoms of Schizophrenia: Hallucinations and Delusions01:30

Positive Symptoms of Schizophrenia: Hallucinations and Delusions

Schizophrenia is a complex mental health disorder that can manifest with various positive symptoms, including thought, movement, and behavior disorders. These symptoms significantly disrupt cognitive and motor functions, leading to profound effects on an individual's ability to engage with the world.
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes loosely...
Negative and Cognitive Symptoms of Schizophrenia01:30

Negative and Cognitive Symptoms of Schizophrenia

Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...